Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0242706 (
hyperoxia
)
5,219
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Bronchopulmonary dysplasia (BPD) is a pulmonary disorder that causes significant morbidity and mortality in premature infants. BPD is pathologically characterized by inflammation, fibrosis, and mucosal necrosis, which leads to emphysematous coalescence of alveoli. We tested the hypothesis that azithromycin, a macrolide antibiotic, would decrease the severity of lung injury in an animal model of BPD. Sixty-three rat pups were randomly divided equally into control,
hyperoxia
, and
hyperoxia
plus azithromycin groups. The
hyperoxia
groups were exposed to > 95% oxygen from days of life 4 to 14. On day 14, the animals were processed for lung histology and tissue analysis. Lung morphology was assessed by mean linear intercept, a measure of alveolar size, with larger values corresponding to lungs that are more emphysematous. The degree of lung inflammation was assessed by quantifying interleukin-6 (IL-6) from lung homogenate. Fifty pups survived to day 14 (control = 21,
hyperoxia
= 11,
hyperoxia
+ azithromycin = 18). Mortality was increased in the
hyperoxia
group versus the control group (p < .0001). Treatment with azithromycin improved survival in animals subjected to
hyperoxia
(p < .05).
Azithromycin
significantly decreased lung damage as determined by the mean linear intercept in the
hyperoxia
groups (p < .001). Finally, azithromycin-treated pups had lower levels of IL-6 in lung homogenate from the
hyperoxia
groups (p < .05).
Azithromycin
treatment resulted in improved survival, less emphysematous change, and decreased IL-6 levels in an animal model of BPD.
...
PMID:Azithromycin protects against hyperoxic lung injury in neonatal rats. 1796 79
Effects of
hyperoxia
on lethality in mice with Pseudomonas aeruginosa pneumonia were defined, and protective roles of macrolides were examined both in vitro and in vivo. Sub-lethal
hyperoxia
accelerated lethality of mice with P. aeruginosa pneumonia. Bacterial number was not different in the lungs, but higher in the liver of mice in hyperoxic conditions. Filter-sterilized culture supernatants of bacteria induced loss of viability of alveolar epithelial cells, which was exaggerated in
hyperoxia
. Metalloprotease blocking by inhibitor or gene-disruption in bacteria resulted in partial reduction of cytotoxic activity in culture supernatants. Co-culture of bacteria with sub-inhibitory concentrations of macrolides, such as azithromycin, reduced cytotoxic activity in the culture supernatants.
Azithromycin
provided significant survival benefit in
hyperoxia
-pneumonia model, which was associated with suppression of bacterial dissemination to extra-pulmonary organs. These results suggest that
hyperoxia
serves as an important cofactor for bacterial dissemination and lethality of P. aeruginosa pneumonia. Our data identify the potential of macrolides to protect individuals with P. aeruginosa pneumonia in the setting of
hyperoxia
.
...
PMID:Hyperoxia exaggerates bacterial dissemination and lethality in Pseudomonas aeruginosa pneumonia. 1916 11